Valneva SE

30
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0004056851
EUR
3.70
-0.03 (-0.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Valneva SE Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-21.00
-105.00
-160.00
-91.00
-75.00
-8.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-145.00
1.00
36.00
166.00
-6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-84.00
-214.00
-254.00
68.00
133.00
3.00
Cash Flow from Investing Activities
74.00
-21.00
-29.00
-93.00
-19.00
-10.00
Cash Flow from Financing Activities
50.00
75.00
224.00
162.00
26.00
-5.00
Net Cash Inflow / Outflow
42.00
-160.00
-60.00
142.00
139.00
-12.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
0.00
3.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Valneva SE
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
-21.514
-139.6
118.00
84.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.394
159.8
-170.00
-107.13%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-84.825
112
-196.00
-175.74%
Cash Flow from Investing Activities
74.554
-108
182.00
169.03%
Cash Flow from Financing Activities
50.651
37.4
13.00
35.43%
Net Cash Inflow / Outflow
42.191
40.7
2.00
3.66%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.811
-0.7
1.00
358.71%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 60.38% vs 15.81% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-84.83
-214.10
60.38%